American Renal sets IPO price range
American Renal Associates Holdings Inc has set the terms of its pending IPO. American Renal plans to sell 7.5 million shares at a price range between $20 to $23 a share. The company’s stock plans to trade under the NYSE ticker “ARA.” Centerbridge Partners owns 79 percent of American Renal before the IPO, according to an SEC filing.
11 April 2016•2 mins read
